<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr96-1358863X20932640">
 <label>96</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Abraham</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Anzueto</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Gutierrez</surname>
    <given-names>G</given-names>
   </name>
  </person-group>, 
  <etal>et al</etal>
  <article-title>Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group</article-title>. 
  <source>Lancet</source>
  <year>1998</year>; 
  <volume>351</volume>: 
  <fpage>929</fpage>â€“
  <lpage>933</lpage>.
  <pub-id pub-id-type="pmid">9734938</pub-id>
 </mixed-citation>
</ref>
